Gregory Lesinski, PhD

Professor
Emory University, United States

Presentation(s):

• 55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma

  Friday, March 24, 2023
  10:04 AM – 10:14 AM

  Disclosure information not submitted.